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Compounds from fermented noni exudates (fNE)
selectively kill human cancer cells
Alexandra Blumer, Robert Borucki, Shaina Arambula, Haley Huggins, Iris Yang, Ashlee Tietje, Dr.
Yanzhang Wei
Clemson University Biological Sciences
Abstract

Noni and Tea Leaf Extract Effects on A549 tumor cells
1.8

Key:
p<.05 = *
p<.01 = **
p<.001 = ***

1.6

1.4

1.2
Fold Change

Our recent studies involving fermented noni exudates (fNE) made from
noni (Morinda citrifolia) have shown promising anti-cancer activities. Using an
in vitro cell culture system, this study examines dozens of compounds isolated
from fNE in order to identify specific compounds preferentially toxic to tumor
cells. The compounds at concentrations of 20, 5, or 2 μg/ml were added to
NL-20 non-tumor lung cells or A549 lung carcinoma cells and incubated for 48
hours. The cytotoxicity of the compounds on the cells was measured using the
MTS cell proliferation assay. Several compounds were found selectively
effective in killing more A549 tumor cells than NL-20 cells. An antioxidant
assay was then performed to investigate if a correlation exists between
antioxidant activity and selective cancer cell killing in our samples. We found
that samples BGS, C2, BGL, and C1 had the highest amount of antioxidant
activity. Of these samples, only C2 showed significant selective A549 cell
killing (p<.05 at 2μg/ml). Further testing is necessary to determine the
mechanism of action and its possible role in immune activation.
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Figure 1: Noni and tea leaf extract effects on A549 tumor cells: After testing each of our various noni and tea leaf samples, we were able to see which
samples were effective in killing A549 tumor cells.

Significant A549 killing cells effect on NL20 non-cancer cells
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Once exposed to noni samples, the cells’ viability was determined in both
normal (293 and NL-20) and in cancerous (DU-145 and A549) cell lines. A favorable
trend was indicated by a decrease in cancer cell survival and an increase or state of
stability in the survival of normal cells. Twenty-five samples were tested, but only six
samples significantly demonstrated the desired trend after 48 hours of incubation.
Certain samples (PPE10AC at 20μg/μl) were able to selectively kill DU-145 cells
(p<.001) while not affecting the stability of the 293 cells (Figure 1). Other samples (C2
at 20μg/μl and 5μg/μl) showed the ability to significantly increase the growth of 293
normal cells (p<.001) while also decreasing (20μg/μl, p<.05) or keeping stable (5μg/μl)
the DU-145 cancerous cells. We saw similar trends with the A549/NL-20 cell lines
(Figure 2). Again, certain samples (NCEERM15, PPE10AC, and PPE2 all at 20μg/μl)
displayed the ability to selectively kill A549 cancerous cells (p<.01) while not
significantly changing the stability of the NL-20 normal cells. To further investigate how
time of noni sample exposure would influence cell proliferation, these samples were
analyzed after 24-hour, 48-hour, and 72-hour incubations.
After 24 hours of incubation, NL-20 cells exposed to C2 noni extract at 20μg/μl
yielded significantly increased cellular growth (p<.001) and slightly decreased A549
growth (Figure 3).
After 48 hours, these trends continued, and there was a significant decrease in
A549 cellular growth when exposed to PPE10AC (p<.001), PPE2 (p<.001), NCEERM15
(p<.05), and P1H (p<.001), each at 20μg/μl dilutions (Figure 4). PPE10AC yielded the
greatest decrease in A549 cells of all the extracts.
After a 72 hour incubation, some samples (NCEERM15 at 20μg/μl) increased
the significance of selectively killing A549 cells (p<.05 at 48 hours to p<.001 at 72
hours). This suggests that while some samples, such as PPE2, were able to selectively
kill A549 cells (p<.001) after only 24 hours, other samples took longer to reach their
peak effectiveness (NCEERM15 at 20μg/μl).
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Figure 3: Significant A549 killing cells effect on NL20 non-cancer cells: After looking at which samples were statistically significant in their killing of A549
tumor cells, we examined which samples also left the NL20 non-cancer cells unharmed. We found that many exhibited this trend, while tea leaf samples 1 20, 7
20, and 7 10 were most successful in promoting NL20 cell growth while having a significant decrease in A549 cells

Materials & Methods
In each trial, the A549 human lung carcinoma and NL-20 non-tumor lung cells
were plated on to separate 96 well plates with 5000 cells/well. The noni samples,
acquired from collaborators in Hawaii, were diluted to concentrations of 20μg/μl,
5μg/μl, and 2μg/μl, and 20μl of each diluted Noni sample was added in each well.
These plates were incubated for 48 hours at 37˚C. The plates were centrifuged at
6000g for one minute to secure cells to the bottom of the well. The media was then
removed and 20μl of an MTS/PMS solution was added. In some trials, an additional
wash step of 100μl of DPBS solution was utilized. After an additional four hours of
incubation at 37˚C, the plates were read at 490nm. The data given from the plate
reader was then analyzed using a two-way ANOVA in order to determine the
statistical significance of our samples in selectively killing tumor cells.
To further investigate antioxidant activity in our noni samples, we used a
working protocol developed from the Sigma-Aldrich Antioxidant Assay Kit. To start,
we diluted all of our Noni samples to a concentration of 2μg/μl. As all of our samples
had been previously diluted with DMSO at differing concentrations, we created 10%,
20%, and 100% DMSO controls. We also diluted the 10X Assay buffer to a 1X Assay
buffer and made a myoglobin working solution and an ABTS working solution
according to protocol. Six Trolox standard working solutions were also created
according to protocol. In each well, we added 10μl of Noni sample or control, 20μl of
myoglobin working solution and 150μl of ABTS working solution. After incubating for
five minutes at room temperature, 100μl of stop solution was added. In control cells,
10μl of the sample was added followed by 270μl of ultrapure water. The absorbance
was then read at 405nm using a plate reader. To analyze the data, a standard curve
was created using the data from the Trolox standards. The equation generated from
the line of best fit was then utilized to obtain the antioxidant activity for each sample
after adjusting for the dilution factor.
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Introduction
Noni (Morinda citrifolia) is small tree originating in Southern Asia and
Polynesia. Parts of this tree, including the fruit, have been used in folk medicine for
close to 3000 years (1). It is said to have a broad range of therapeutic effects,
including anti-inflammatory, hypotensive, immune enhancing, and anti-tumor effects
(2). The Noni fruit has come under study more recently and has been reported to
enhance immune activity by activation T and B cells (3). Studies have also shown
that intraperitoneal (i.p.) injections of fermented noni exudate (fNE) has caused
proliferation of NK and T cells, as well as stimulation of dendritic cells (4, 5).
Recent studies have also shown Noni fruit to have promising anti-tumor
properties. C57BL/6J mice with S180 tumor cells received i.p. injections of fNE,
which caused both increased granulocyte and NK cell counts, as well as a rejection
of the tumors in over 85% of the mice (4). There has been some work that identified
the BuOH fraction of fNE as the one with therapeutic properties (6) but little work has
been done on specific extracts looking directly at the anti-tumor properties of unique
compounds in the fNE. This research looks at several specific compounds in the
fNE and their role in preventing tumor growth and cell proliferation in human cell
lines.

Results & Discussion

Results

This research shows that there is significant evidence that select extracts from
Noni juice have the ability to selectively kill cancerous cells while increasing or
maintaining the stability of non cancerous cell lines. Certain extracts have proven
effective in both DU-145/293 and A549/NL-20 human cell lines. We found that the most
potent samples can exhibit significant results in as little as 24 hours, while other
compounds take between 48 and 72 hours to display the desired trend. These early
results are promising in the hopes of fighting cancer.
Using components of noni fruit to fight cancer is the goal of this research;
however, there is a great deal of research to be done before this goal can be met. The
next step in this project is to expand upon the cell lines being tested. We have already
tested prostate and lung carcinoma cells. Next we will test melanoma and breast
cancer cells to determine if the effects of fNE differs between cell lines.
Successful therapeutics are often cocktails of complementing drugs. For this
reason, combining extracts to see if the effectiveness increases will also be assessed.
For example, C2 enhanced the growth of normal cells and PPE10AC was successful at
targeting tumor cells. Therefore, they may work together for a more successful
treatment option. Once the basic effects of fNE are determined, the mechanism
through which the tumor cells are being killed will be assessed. The methods to
determine if fNE is inducing apoptosis in cancerous cells, Caspase and Annexin-V
assays, will be utilized.
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